Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1021)
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
245,066
Price
$0.38
Total Value
$93.13K
Shares Held After
5,076,685
% of Holdings
4.6%
Axsome Therapeutics, Inc. (AXSM)
JEFFS ROGER — Director
Shares
286
Price
$249.12
Total Value
$71.25K
Shares Held After
58,367
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
548,580
Price
$7.91
Total Value
$4.34M
Shares Held After
16,231,717
% of Holdings
3.4%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,674
Price
$16.82
Total Value
$78.62K
Shares Held After
71,365
% of Holdings
6.1%
Jazz Pharmaceuticals plc (JAZZ)
Patil Neena M — EVP & Chief Legal Officer
Shares
1,200
Price
$231.83
Total Value
$278.20K
Shares Held After
51,549
% of Holdings
2.3%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
1,780
Price
$26.05
Total Value
$46.37K
Shares Held After
27,435
% of Holdings
6.1%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
3,127
Price
$26.03
Total Value
$81.40K
Shares Held After
29,215
% of Holdings
9.7%
uniQure N.V. (QURE)
Gut Robert — Director
Shares
2,645
Price
$26.07
Total Value
$68.96K
Shares Held After
32,342
% of Holdings
7.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,170
Price
$25.00
Total Value
$54.25K
Shares Held After
63,443
% of Holdings
3.3%
LIGAND PHARMACEUTICALS INC (LGND)
Aryeh Jason — Director
Shares
500
Price
$250.00
Total Value
$125.00K
Shares Held After
107,080
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
3,405
Price
$251.62
Total Value
$856.75K
Shares Held After
26,969
% of Holdings
11.2%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
697
Price
$249.53
Total Value
$173.92K
Shares Held After
30,374
% of Holdings
2.2%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
232
Price
$248.11
Total Value
$57.56K
Shares Held After
31,071
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
LAMATTINA JOHN L — Director
Shares
257
Price
$247.22
Total Value
$63.54K
Shares Held After
31,303
% of Holdings
0.8%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
614
Price
$86.89
Total Value
$53.35K
Shares Held After
1,095,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,305
Price
$86.27
Total Value
$198.85K
Shares Held After
1,096,601
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,577
Price
$85.19
Total Value
$134.34K
Shares Held After
1,098,906
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,080
Price
$84.18
Total Value
$90.91K
Shares Held After
1,100,483
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
7,654
Price
$82.78
Total Value
$633.60K
Shares Held After
1,101,563
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
6,770
Price
$82.21
Total Value
$556.56K
Shares Held After
1,109,217
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
17,566
Price
$75.00
Total Value
$1.32M
Shares Held After
73,411
% of Holdings
19.3%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
3,711
Price
$75.00
Total Value
$278.32K
Shares Held After
73,411
% of Holdings
4.8%
Clearmind Medicine Inc. (CMND)
HRT FINANCIAL LP — 10% Owner
Shares
2,159,052
Price
$0.15
Total Value
$330.33K
Shares Held After
2,063,266
% of Holdings
104.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
28,237
Price
$66.30
Total Value
$1.87M
Shares Held After
1,418,453
% of Holdings
2.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
103,301
Price
$65.54
Total Value
$6.77M
Shares Held After
1,446,690
% of Holdings
6.7%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
14,416
Price
$64.48
Total Value
$929.55K
Shares Held After
1,549,991
% of Holdings
0.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
3,051
Price
$0.37
Total Value
$1.13K
Shares Held After
378,666
% of Holdings
0.8%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
42,872
Price
$0.37
Total Value
$15.86K
Shares Held After
5,321,751
% of Holdings
0.8%
Axsome Therapeutics, Inc. (AXSM)
JEFFS ROGER — Director
Shares
286
Price
$246.18
Total Value
$70.41K
Shares Held After
58,653
% of Holdings
0.5%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
103
Price
$7.00
Total Value
$721.00
Shares Held After
15,683,137
% of Holdings
0.0%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$107.68
Total Value
$969.12K
Shares Held After
7,825
% of Holdings
53.5%
Lyell Immunopharma, Inc. (LYEL)
Shook David — Chief Medical Officer
Shares
1,977
Price
$12.64
Total Value
$24.99K
Shares Held After
20,923
% of Holdings
8.6%
FRACTYL HEALTH, INC. (GUTS)
Rajagopalan Harith — Director
Shares
25,000
Price
$0.73
Total Value
$18.25K
Shares Held After
540,557
% of Holdings
4.6%
FRACTYL HEALTH, INC. (GUTS)
Sheffield Ian — Director
Shares
35,000
Price
$0.73
Total Value
$25.53K
Shares Held After
35,000
% of Holdings
100.0%
FRACTYL HEALTH, INC. (GUTS)
BRADLEY WILLIAM — Director
Shares
68,493
Price
$0.73
Total Value
$50.33K
Shares Held After
84,622
% of Holdings
80.9%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Kung Winston — Director
Shares
2,026
Price
$7.91
Total Value
$16.03K
Shares Held After
12,140
% of Holdings
14.3%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Jenkins John Kenneth — Director
Shares
4,800
Price
$7.91
Total Value
$37.99K
Shares Held After
3,833
% of Holdings
55.6%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Altmeyer Anne — Director
Shares
2,412
Price
$7.91
Total Value
$19.09K
Shares Held After
7,579
% of Holdings
24.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$557.03
Total Value
$44.56K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
285
Price
$555.29
Total Value
$158.26K
Shares Held After
40,593
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
933
Price
$554.56
Total Value
$517.41K
Shares Held After
40,878
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
587
Price
$553.64
Total Value
$324.99K
Shares Held After
41,811
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
90
Price
$551.60
Total Value
$49.64K
Shares Held After
42,398
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
156
Price
$550.59
Total Value
$85.89K
Shares Held After
42,488
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
508
Price
$549.70
Total Value
$279.25K
Shares Held After
42,644
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
246
Price
$548.63
Total Value
$134.96K
Shares Held After
43,152
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
385
Price
$547.09
Total Value
$210.63K
Shares Held After
43,398
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
215
Price
$546.14
Total Value
$117.42K
Shares Held After
43,783
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
914
Price
$545.10
Total Value
$498.22K
Shares Held After
43,998
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
867
Price
$544.33
Total Value
$471.93K
Shares Held After
44,912
% of Holdings
1.9%
Showing 51–100 of 1021 transactions (page 2 of 21)